MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia
about
Oncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expressionmiR-155 as a Biomarker in B-Cell MalignanciesMicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemiaMicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemiaMicroRNAs in B-cell lymphomas: how a complex biology gets more complexMicroRNAs and B cell receptor signaling in chronic lymphocytic leukemiaAn interactive web application for the dissemination of human systems immunology dataNetwork Biomarkers Constructed from Gene Expression and Protein-Protein Interaction Data for Accurate Prediction of LeukemiaUpregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A.Differential co-expression analysis reveals a novel prognostic gene module in ovarian cancerAbnormal microRNA expression in Ts65Dn hippocampus and whole blood: contributions to Down syndrome phenotypes.Differential microRNA expression following infection with a mouse-adapted, highly virulent avian H5N2 virus.Clinical and biological relevance of genomic heterogeneity in chronic lymphocytic leukemia.Signal transducer and activator of transcription-3 induces microRNA-155 expression in chronic lymphocytic leukemia.HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL).Transcription factor and microRNA-regulated network motifs for cancer and signal transduction networks.IL-4 Up-Regulates MiR-21 and the MiRNAs Hosted in the CLCN5 Gene in Chronic Lymphocytic Leukemia.Kruppel-Like Factor 2-Mediated Suppression of MicroRNA-155 Reduces the Proinflammatory Activation of Macrophages.k-Neighborhood decentralization: a comprehensive solution to index the UMLS for large scale knowledge discovery.A Double Negative Loop Comprising ETV6/RUNX1 and MIR181A1 Contributes to Differentiation Block in t(12;21)-Positive Acute Lymphoblastic Leukemia.Inhibition of MiR-155 suppresses cell migration in nasopharyngeal carcinoma through targeting ZDHHC2.Prediction of response to therapy with ezatiostat in lower risk myelodysplastic syndrome.MINT: a multivariate integrative method to identify reproducible molecular signatures across independent experiments and platformsExploring the nature of prediagnostic blood transcriptome markers of chronic lymphocytic leukemia by assessing their overlap with the transcriptome at the clinical stage.MicroRNAs in Acute Myeloid Leukemia and Other Blood Disorders.miR-155 acts as an anti-inflammatory factor in atherosclerosis-associated foam cell formation by repressing calcium-regulated heat stable protein 1.MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid MalignanciesOtosclerosis Associated with a De Novo Mutation -832G > A in the TGFB1 Gene Promoter Causing a Decreased Expression Level.Activation of miR200 by c-Myb depends on ZEB1 expression and miR200 promoter methylationLong non-coding RNAs in haematological malignancies.Argonaute 2 sustains the gene expression program driving human monocytic differentiation of acute myeloid leukemia cells.miR-155 Regulated Inflammation Response by the SOCS1-STAT3-PDCD4 Axis in Atherogenesis.Role of microRNAs in lymphoid biology and disease.Uncovering the DNA methylome in chronic lymphocytic leukemia.MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer.NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms.Functionally distinct roles for different miR-155 expression levels through contrasting effects on gene expression, in acute myeloid leukaemia.MiR-155/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemia.Oncogenic microRNA-155 and its target PU.1: an integrative gene expression study in six of the most prevalent lymphomas.Comparison of microRNA expression in high-count monoclonal B-cell lymphocytosis and Binet A chronic lymphocytic leukemia.
P2860
Q24625246-74E2FCCF-5BC8-4350-8FB1-A3D1927006EFQ26746573-FBDD2B95-20E2-499F-9F15-3043A2A3B824Q26766288-E845FB68-F644-48A5-8931-A0071C1BEA27Q28241703-D3768D5F-6832-4AE9-B2C9-95F87BFD23F9Q28254647-61961B7B-3BCE-45EF-B435-D02B00DBEF00Q28289170-9F5C1C5B-EBEF-45CB-A636-E63251C717DDQ28648166-4D1B38B6-2D8D-4614-BA41-1A7DACF35174Q31167575-D111C2BC-8C48-44C7-A64A-28A64F871F6EQ33889404-CB4ED178-0103-4560-A229-22EBB894B1FFQ33890351-E1B6CDD5-AAF6-412D-9C09-AD1E70C88E00Q34229190-71C80529-3AD8-4F40-9A29-2E64FE8BFDFFQ34306292-0D08E18B-3872-4406-A9F1-C7A490B25B7DQ34612039-84503097-B96E-4EC7-A563-8B056147FF62Q34764114-734FBFF8-112A-4CBE-B7D3-315FCEB466AAQ34985471-1E81E469-E317-462D-8277-8E627791C4C3Q35092844-C0E29CB2-2F0C-4B2C-9C00-64D3C3E0ACCBQ35613623-5A8242F2-86AB-4630-933A-D34B6DCCE374Q35787744-C89796DE-220B-451A-8C69-3B7515EEBC80Q35836587-EE1C446D-D53D-4F50-92D8-5928CB806A4DQ35845024-A3162C62-15CF-4EEE-A48E-03E0036B6974Q35959329-FA41BCE2-5F69-4F4E-BEF1-A59EEEC96BE4Q36125613-6FEA804D-128C-4F5D-879A-23511577D160Q36292006-B497D4D6-D660-49F7-8F3B-02E6BEBD0C57Q36315242-B6B736DC-278A-41E5-98AA-55E9B1E1AB54Q36422143-BD4F58C2-FF46-4191-A1F7-CBDB6ED13D64Q36602255-BA97FB4E-C476-4ADD-8027-21E0C3E3017EQ36602853-4EDA9BB8-8020-42FB-A63A-17C57C382F11Q37087289-B833DC16-7ABD-4DCB-AEB8-6F0B5FEC80FDQ37126203-B6C18654-7122-4426-9B31-6CFCE6D2A2E7Q37139037-DA14640A-D3BC-4DC9-8CBA-46248ED36373Q37357102-4311BC3C-4238-4B6D-BF10-6C9A63E395E8Q37397092-2D9A1AA0-9AF1-40E2-8825-4C7D6A88705BQ37868870-3CE47105-D0B3-4639-AB2F-178803686806Q38074267-B8679E4E-D512-4BE3-9FAA-7C06724A997EQ38095501-D47620B1-7648-4818-9B67-581E62EA039EQ38988815-943EE47E-00D6-49B8-B0A3-6D70B34A974DQ39292054-74E48A57-214C-4E5B-995C-86646931E476Q41316598-153D9AC1-0D04-40D0-B86F-E9E4735D458EQ41495243-613B0F43-278E-408D-A471-6F74B785A7AEQ41500318-49D6677C-A640-4D54-B6DC-F3EE820A059B
P2860
MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia
@ast
MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia
@en
MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia
@nl
type
label
MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia
@ast
MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia
@en
MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia
@nl
prefLabel
MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia
@ast
MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia
@en
MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia
@nl
P2093
P50
P3181
P1433
P1476
MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia
@en
P2093
Jiri Mayer
Marek Mraz
Pavel Burda
Petra Obrtlikova
Sarka Pospisilova
Tomas Stopka
Vit Pospisil
P304
P3181
P356
10.1182/BLOOD-2010-05-285064
P407
P50
P577
2011-02-04T00:00:00Z